Kadmon Holdings, Inc. (KDMN): Price and Financial Metrics
KDMN Price/Volume Stats
| Current price | $9.50 | 52-week high | $9.50 |
| Prev. close | $9.48 | 52-week low | $3.19 |
| Day low | $9.48 | Volume | 10,424,500 |
| Day high | $9.50 | Avg. volume | 5,109,463 |
| 50-day MA | $8.58 | Dividend yield | N/A |
| 200-day MA | $5.34 | Market Cap | 1.70B |
KDMN Stock Price Chart Interactive Chart >
Kadmon Holdings, Inc. (KDMN) Company Bio
Kadmon Holdings, LLC discovers, develops, and commercializes small molecules and biologics to address unmet medical needs. The company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus infection; co-promotes a product for chronic weight management; distributes products for chorea, cytomegalovirus retinitis, and for the prevention of CMV disease. The company is based in New York City, New York
KDMN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KDMN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 112.05% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -8.39% |